作者：
Wojciech,Czardybon [1]
;
Renata,Windak [1]
;
Aniela,Gołas [1]
;
Michał,Gałęzowski [1]
;
Aleksandra,Sabiniarz [1]
;
Izabela,Dolata [1]
;
Magdalena,Salwińska [1]
;
Paweł,Guzik [1]
;
Magdalena,Zawadzka [1]
;
Ewelina,Gabor-Worwa [1]
;
Bożena,Winnik [1]
;
Małgorzata,Żurawska [1]
;
Ewa,Kolasińska [1]
;
Ewelina,Wincza [1]
;
Marta,Bugaj [1]
;
Monika,Danielewicz [1]
;
Eliza,Majewska [1]
;
Milena,Mazan [1]
;
Grzegorz,Dubin [2]
;
Monika,Noyszewska-Kania [3]
;
Ewa,Jabłońska [3]
;
Maciej,Szydłowski [3]
;
Tomasz,Sewastianik [3]
;
Bartosz,Puła [4]
;
Anna,Szumera-Ciećkiewicz [5]
;
Monika,Prochorec-Sobieszek [5]
;
Elżbieta,Mądro [4]
;
Ewa,Lech-Marańda [4]
;
Krzysztof,Warzocha [6]
;
Jerome,Tamburini [4]
;
Przemysław,Juszczyński [7]
;
Krzysztof,Brzózka [8]
作者单位：
Selvita S.A., Krakow, Poland.
[1]
Malopolska Centre of Biotechnology, Krakow, Poland.
[2]
Dept. of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
[3]
Dept. of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
[4]
Dept. of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
[5]
Dept. of Hematology and Transfusion Medicine, Centre of Postgraduate Medical Education, Marymoncka, Warsaw, Poland.
[6]
Institut Cochin, Département Développement, Reproduction, Cancer, Paris, France.
[7]
Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
[8]
Equipe Labellisée, Ligue Nationale Contre le Cancer (LNCC), Paris, France.
[9]
DOI
10.18632/oncotarget.24747
PMID
29682194
发布时间
2019-11-20
换一批
换一批
